Steroid elution at the electrode-tissue interface revolutionized cardiac pacing by enabling reliable and significantly lower stimulation thresholds.
Answers are grounded in this paper and cite their sources.
May support steroid-eluting leads for low-threshold pacing; extends prior reviews but leaves open prospective validation in modern devices.
The electrode-tissue interface is that area lying between the cathode of a low-voltage implantable pacemaker or cardioverter-defibrillator (ICD) lead and the endocardium or epi-myocardium of the cardiac chamber being paced. The electrical stimulus that is delivered to this interface is responsible for myocyte depolarization with consequent cardiac contraction. The process by which this occurs is reasonably well understood and any explanation requires a basic understanding of the physics and cellular electrophysiology of pacing. The effective and efficient delivery of electrical energy to the myocardium via the lead is dependent on many factors to be discussed in this review. However, despite numerous evolutionary changes occurring in the cathode's material, design, and surface configuration, it was not until the incorporation of steroid-elution to the electrode-tissue interface that reliable and significantly low stimulation threshold cardiac pacing became possible.
No takes yet. Share an insight, caveat, or question.
Harry G. Mond (1992) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: